Related content

Impact of EGFR tyrosine kinase inhibitors versus chemotherapy on the development of leptomeningeal metastasis in never smokers with advanced adenocarcinoma of the lung

By Lee Youngjoo   Han Ji-Youn   Kim Heung   Yun Tak   Lee Geon   Kim Hyae   Lee Jin  

Journal of Neuro-Oncology, Vol. 115, Iss. 1, 2013-10 ,pp. : 95-101

Springer Publishing Company

Access to resources Recommend Favorite

Ethnicity affects EGFR and KRAS gene alterations of lung adenocarcinoma

By                  

Oncology Letters, Vol. 10, Iss. 3, 2015-01 ,pp. : 1775-1782

Spandidos Publications

Access to resources Recommend Favorite

Synergistic cell growth inhibition by the combination of amrubicin and Akt-suppressing agents in K-ras mutation-harboring lung adenocarcinoma cells: Implication of EGFR tyrosine kinase inhibitors

By                            

International Journal of Oncology, Vol. 44, Iss. 3, 2014-01 ,pp. : 685-692

Spandidos Publications

Access to resources Recommend Favorite

A case of lung adenocarcinoma with a concurrent EGFR mutation and ALK rearrangement: A case report and literature review

By                    

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 4370-4375

Spandidos Publications

Access to resources Recommend Favorite

Biological Characteristics and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Efficacy of EGFR Mutation and its Subtypes in Lung Adenocarcinoma

By Lu Rong-li   Hu Cheng-Ping   Yang Hua-ping   Li Yuan-yuan   Gu Qi-hua   Wu Lielin  

Pathology & Oncology Research, Vol. 20, Iss. 2, 2014-04 ,pp. : 445-451

Springer Publishing Company

Access to resources Recommend Favorite